A strategy to design protein-based antagonists against type I cytokine receptors.
Ullrich T, Klimenkova O, Pollmann C, Lasram A, Hatskovska V, Maksymenko K, Milijaš-Jotić M, Schenk L, Lengerke C, Hartmann MD, Piehler J, Skokowa J, ElGamacy M.
Ullrich T, et al. Among authors: hartmann md.
PLoS Biol. 2024 Nov 26;22(11):e3002883. doi: 10.1371/journal.pbio.3002883. eCollection 2024 Nov.
PLoS Biol. 2024.
PMID: 39591631